Dental Extractions Among Renal Transplant Recipients
Launched by UNIVERSITY OF SAO PAULO · Sep 9, 2015
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
Investigators did not found scientific evidences neither evidence-based research, which support the idea that stable kidney recipients have increased risk for delayed socket repair and wound healing after exodontia or that infections resulted by oral surgery are more common in these patients, despite the drug-induced immunosuppression which they use.
Since there is no scientific evidence about the increased risk of post-exodontic infection, not even about a disorder on the alveolar repair chronology, after exodontia performed in kidney recipients, the aim of our study will be prospectively...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • renal transplantation for more than 6 months
- Exclusion Criteria:
- • use of antibiotic in the previous month, use of bisphosphonate therapy, use of illicit drugs, chronic use of alcohol, having a dental emergency,having acute dental or periodontal infections, having a cognitive impairment.
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sp, Brazil
São Paulo, , Brazil
Patients applied
Trial Officials
Marina Gallottini
Principal Investigator
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials